Corcept Therapeutics Incorporated (CORT) vs Praxis Precision Medicines, Inc. (PRAX)
- Corcept Therapeutics Incorporated CORT 72.94 +1.83%
- Praxis Precision Medicines, Inc. PRAX 276.09 +5.14%
Corcept Therapeutics Incorporated and Praxis Precision Medicines, Inc. are both Biotechnology companies. Corcept Therapeutics Incorporated and Praxis Precision Medicines, Inc. are of similar size ($7.8B and $7.3B). Praxis Precision Medicines, Inc. has negative trailing earnings, so its P/E is not meaningful; Corcept Therapeutics Incorporated trades at 47.5×. Praxis Precision Medicines, Inc. grew revenue faster over the last twelve months: 249.5% against 30.0%. Corcept Therapeutics Incorporated has the higher net margin (16.5% vs 0.00%) and the higher return on invested capital (15.0% vs −40.6%). Across the 17 metrics below, Corcept Therapeutics Incorporated leads on 11 and Praxis Precision Medicines, Inc. on 6.
Valuation
Profitability
| Metric | CORT | PRAX | Biotechnology median |
|---|---|---|---|
| Gross margin | 98.54% | 100.00% | 65.16% |
| Operating margin | 11.51% | 0.00% | 0.00% |
| Net margin | 16.54% | 0.00% | 0.00% |
| Free cash flow margin | 20.20% | 0.00% | 0.00% |
| Return on equity | 21.74% | (38.86%) | (50.12%) |
| Return on assets | 17.16% | (36.80%) | (45.60%) |
| Return on invested capital | 14.97% | (40.58%) | 0.00% |
Growth
Health
Dividend
Size
Any metric, up to five companies and an Excel export Powerpack